Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangfeng Li

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Plos Pathogens|February 4, 2021
Evidence for distinct mechanisms of small molecule inhibitors of filovirus entryAdam Schafer, Rui Xiong, Laura Cooper, et al.
Molecular and Cellular Biology|September 13, 2006
Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3Ho-Jin Koh, David E Arnolds, Nobuharu Fujii, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancerDaniel R Principe, Rui Xiong, Yangfeng Li, et al.
Journal of Medicinal Chemistry|November 21, 2019
Design and Synthesis of Basic Selective Estrogen Receptor Degraders for Endocrine Therapy Resistant Breast CancerYunlong Lu, Lauren M Gutgesell, Rui Xiong, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Plos Pathogens|February 4, 2021
Evidence for distinct mechanisms of small molecule inhibitors of filovirus entryAdam Schafer, Rui Xiong, Laura Cooper, et al.
Molecular and Cellular Biology|September 13, 2006
Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3Ho-Jin Koh, David E Arnolds, Nobuharu Fujii, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancerDaniel R Principe, Rui Xiong, Yangfeng Li, et al.
Journal of Medicinal Chemistry|November 21, 2019
Design and Synthesis of Basic Selective Estrogen Receptor Degraders for Endocrine Therapy Resistant Breast CancerYunlong Lu, Lauren M Gutgesell, Rui Xiong, et al.
Pageof 7